3DDG
GOLGI MANNOSIDASE II complex with (3R,4R,5R)-3,4-Dihydroxy-5-({[(1R)-2-hydroxy-1 phenylethyl]amino}methyl) methylpyrrolidin-2-one
3DDG の概要
エントリーDOI | 10.2210/pdb3ddg/pdb |
関連するPDBエントリー | 1HTY 1QWN 2ALW 2F18 2F1A 2F1B 2F7O 2F7P 3BLB 3BUB 3DDF |
分子名称 | alpha-mannosidase 2, 2-acetamido-2-deoxy-beta-D-glucopyranose, PHOSPHATE ION, ... (7 entities in total) |
機能のキーワード | gh38 glycosidase, hydrolase |
由来する生物種 | Drosophila melanogaster (fruit fly) |
タンパク質・核酸の鎖数 | 1 |
化学式量合計 | 120481.70 |
構造登録者 | |
主引用文献 | Fiaux, H.,Kuntz, D.A.,Hoffman, D.,Janzer, R.C.,Gerber-Lemaire, S.,Rose, D.R.,Juillerat-Jeanneret, L. Functionalized pyrrolidine inhibitors of human type II alpha-mannosidases as anti-cancer agents: optimizing the fit to the active site Bioorg.Med.Chem., 16:7337-7346, 2008 Cited by PubMed Abstract: Refining the chemical structure of functionalized pyrrolidine-based inhibitors of Golgi alpha-mannosidase II (GMII) to optimize binding affinity provided a lead molecule that demonstrated nanomolar competitive inhibition of alpha-mannosidases II and an optimal fit in the active site of Drosophila GMII by X-ray crystallography. Esters of this lead compound also inhibited the growth of human glioblastoma and brain-derived endothelial cells more than the growth of non-tumoral human fibroblasts, suggesting their potential for anti-cancer therapy. PubMed: 18599296DOI: 10.1016/j.bmc.2008.06.021 主引用文献が同じPDBエントリー |
実験手法 | X-RAY DIFFRACTION (1.74 Å) |
構造検証レポート
検証レポート(詳細版)をダウンロード